(1S,4R)-4-Boc-aminocyclopent-2-enecarboxylic acid, 95.0%, 1g

Methyl pyridazine-4-carboxylate, 95.0%, 100mg

Recipiente de cristalización DURAN® sin pico, 300 ml, 95 mm, 10 Unidad(es)

N-(Adamantan-1-yl)acetamide, 95.0%, 100g

6-Bromo-1-methylisoquinoline, 97%, 250mg

Methyl 2-(2-bromo-3-chlorophenyl)acetate, 95%, 250mg

4-Iodo-3-methoxybenzaldehyde, 95+%, 10g

Diethyl 2-(1-Methylethylidene)malonate, 97.0%, 100g

4,4'-Diaminobenzanilide>98.0%(HPLC)(T)25g

1-[(4-Fluorophenoxy)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline, 95.0%, 500mg

tert-Butyl 4-benzyl-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate, 98%, 100mg

(2-Acetylthiophen-3-yl)boronic acid, 95.0%, 250mg

2- p -Tolyl-pyrrolidine, 95.0%, 1g